Role of c-MET Inhibitors in Overcoming Drug Resistance in Spheroid Models of Primary Human Pancreatic Cancer and Stellate Cells
Omidreza Firuzi(Shiraz University of Medical Sciences), Elisa Giovannetti(University of Pisa)
Cited by 76
Related Papers
Molecular basis and rationale for combining immune checkpoint inhibitors with chemotherapy in non-small cell lung cancer
|Drug Resistance Updates|2019|198
HGF/MET pathway aberrations as diagnostic, prognostic, and predictive biomarkers in human cancers
|Critical Reviews in Clinical Laboratory Sciences|2019|182
Entrectinib: a potent new TRK, ROS1, and ALK inhibitor
|Expert Opinion on Investigational Drugs|2015|153
Applications and clinical trial landscape using Toll-like receptor agonists to reduce the toll of cancer
|npj Precision Oncology|2023|146
Immunotherapy in NSCLC: A Promising and Revolutionary Weapon
|Advances in experimental medicine and biology|2017|143